Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 11, 2021
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
Tue, August 10, 2021
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
Brian Cheng Maintained (ARCT) at Buy with Increased Target to $85 on, Aug 10th, 2021
Brian Cheng of Cantor Fitzgerald, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy with Increased Target from $71 to $85 on, Aug 10th, 2021.
Brian has made no other calls on ARCT in the last 4 months.
There is 1 other peer that has a rating on ARCT. Out of the 1 peers that are also analyzing ARCT, 0 agree with Brian's Rating of Hold.
This is the rating of the analyst that currently disagrees with Brian
- Gena Wang of "Barclays" Downgraded from Hold to Sell and Decreased Target to $25 on, Monday, June 21st, 2021
